Washburn Capital Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Washburn Capital Management's IDXX Position: Q2 2024 in Review
Washburn Capital Management sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 828 shares — an estimated $447K sold.
Washburn Capital Management first reported a position in IDXX in Q4 2019 and held it in 18 quarters. The position peaked at $1M in Q4 2021. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.
- Washburn Capital Management reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
- Washburn Capital Management sold 828 Idexx Laboratories shares in Q2 2024, an estimated $447K.
- Washburn Capital Management first reported a position in Idexx Laboratories in Q4 2019 and held it in 18 quarters.
- Washburn Capital Management's Idexx Laboratories position peaked at $1M in Q4 2021.
- 1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.
Based on Washburn Capital Management's 13F filing for Q2 2024, filed 25 Jul 2024.